LiVeritas Biosciences

Harnessing Molecular Integrity for Early Informed Decision Making


Press Release: LiVeritas™ Biosciences Launches Mass Spectrometry Outsourcing Solutions

Mass Spec as a Service (MSaaS) Provides Drug Developers with High-Quality Data and Ultra-Fast Turnaround

Read more


Webinar: Phase Appropriate LC-MS Strategy for the Rapid Characterization of Bispecific Antibodies

April 6th 2022 11AM PDT

Read more Watch now
ASMS 2021 - Bruker Breakfast Seminar
Watch now
CASSS Mass Spec 2021